From DNA Copy Number Gains and Tumor Dependencies to Novel Therapeutic Targets for High-Risk Neuroblastoma.

Decaesteker, Bieke; Durinck, Kaat; Van Roy, Nadine; De Wilde, Bram; Van Neste, Christophe; Van Haver, Stéphane; Roberts, Stephen; De Preter, Katleen; Vermeirssen, Vanessa; Speleman, Frank

Decaesteker, Bieke; Durinck, Kaat; Van Roy, Nadine; De Wilde, Bram; Van Neste, Christophe; Van Haver, Stéphane; Roberts, Stephen; De Preter, Katleen; Vermeirssen, Vanessa; Speleman, Frank.

Afiliação

Decaesteker B; Department for Biomolecular Medicine, Ghent University, Medical Research Building (MRB1), Corneel Heymanslaan 10, B-9000 Ghent, Belgium.
Durinck K; Department for Biomolecular Medicine, Ghent University, Medical Research Building (MRB1), Corneel Heymanslaan 10, B-9000 Ghent, Belgium.
Van Roy N; Department for Biomolecular Medicine, Ghent University, Medical Research Building (MRB1), Corneel Heymanslaan 10, B-9000 Ghent, Belgium.
De Wilde B; Department for Biomolecular Medicine, Ghent University, Medical Research Building (MRB1), Corneel Heymanslaan 10, B-9000 Ghent, Belgium.
Van Neste C; Department of Internal Medicine and Pediatrics, Ghent University Hospital, Corneel Heymanslaan 10, B-9000 Ghent, Belgium.
Van Haver S; Department for Biomolecular Medicine, Ghent University, Medical Research Building (MRB1), Corneel Heymanslaan 10, B-9000 Ghent, Belgium.
Roberts S; Department for Biomolecular Medicine, Ghent University, Medical Research Building (MRB1), Corneel Heymanslaan 10, B-9000 Ghent, Belgium.
De Preter K; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Vermeirssen V; Department for Biomolecular Medicine, Ghent University, Medical Research Building (MRB1), Corneel Heymanslaan 10, B-9000 Ghent, Belgium.
Speleman F; Department for Biomolecular Medicine, Ghent University, Medical Research Building (MRB1), Corneel Heymanslaan 10, B-9000 Ghent, Belgium.

J Pers Med ; 11(12)2021 Dec 03.

Article em En | MEDLINE | ID: mdl-34945759

Palavras-chave

DNA copy number gains; MYCN; dependency; drug targets; neuroblastoma

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Risk_factors_studies Idioma: En Revista: J Pers Med Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Bélgica

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google